A CASE SERIES OF HLA-B*58:01 SPECIFIC ALLOPURINOL-INDUCED DRESS/DIHS

被引：0
|
作者：
Diaz, A.
Sani, S.
Mawhirt, S.
Banta, E.
Fonacier, L.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2022年 / 129卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
M050
引用
收藏
页码：S97 / S98
页数：2
相关论文
共 50 条
  • [21] PHARMACOGENETIC HLA-B☆58:01 TESTING TO PREVENT ALLOPURINOL-INDUCED SJS']JS/TEN IN VIETNAMESE POPULATION: A COST-EFFECTIVENESS ANALYSIS
    Duong, K.
    Nguyen, D., V
    Chaiyakunapruk, N.
    Nelson, R. E.
    Malone, D. C.
    VALUE IN HEALTH, 2023, 26 (06) : S76 - S77
  • [22] Validation of a Rapid, Robust, Inexpensive Screening Method for Detecting the HLA-B*58:01 Allele in the Prevention of Allopurinol-Induced Severe Cutaneous Adverse Reactions
    Nguyen, Dinh Van
    Vidal, Christopher
    Chu, Hieu Chi
    Fulton, Richard
    Li, Jamma
    Fernando, Suran L.
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2017, 9 (01) : 79 - 84
  • [23] Immunologic basis for allopurinol-induced severe cutaneous adverse reactions: HLA-B*58:01-restricted activation of drug-specific T cells and molecular interaction
    Lin, Chia-Hsien
    Chen, Jung-Kuei
    Ko, Tai-Ming
    Wei, Chun-Yu
    Wu, Jer-Yuarn
    Chung, Wen-Hung
    Chen, Shih-Yang
    Liao, You-Di
    Hung, Shuen-Iu
    Chen, Yuan-Tsong
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2015, 135 (04) : 1063 - +
  • [24] HLA-B☆58:01 is strongly associated with allopurinol-induced severe cutaneous adverse reactions in Han Chinese patients: a multicentre retrospective case-control clinical study
    Cheng, L.
    Xiong, Y.
    Qin, C. Z.
    Zhang, W.
    Chen, X. P.
    Li, J. .
    Zhou, H. H.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (02) : 555 - 558
  • [25] A novel HLA-B allele: HLA-B*58:01:13
    Zheng, Jie W.
    Xie, Jun H.
    Sun, Ying
    Xiang, Dong
    HLA, 2019, 93 (06) : 492 - +
  • [26] Comparison between the HLA-B*58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions
    Saksit, Niwat
    Nakkam, Nontaya
    Konyoung, Parinya
    Khunarkornsiri, Usanee
    Tassaneeyakul, Wongwiwat
    Chumworathayi, Pansu
    Kanjanawart, Sirimas
    Sukasem, Chonlaphat
    Sangviroon, Alisara
    Pattanacheewapull, Oranuch
    Tassaneeyakul, Wichittra
    JOURNAL OF IMMUNOLOGY RESEARCH, 2017, 2017
  • [27] Fixed drug eruption in a patient of HLA-B*58:01 negative after allopurinol administration: A case report
    Zhang, Ruiqi
    Geng, Hui
    Du, Jiali
    Liu, Meilin
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (06) : 841 - 843
  • [28] HLA-B*58:01 and allopurinol high dose were associated with allopurinol induced cutaneous adverse drug reactions in Thai population
    Sukasem, C.
    Jantararoungtong, T.
    Kuntawong, P.
    Puangpetch, A.
    Koomdee, N.
    Klaewsongkram, J.
    Rerkpattanapipat, T.
    ALLERGY, 2016, 71 : 205 - 206
  • [29] Efficacy of the HLA-B*58:01 Screening Test in Preventing Allopurinol-Induced Severe Cutaneous Adverse Reactions in Patients with Chronic Renal Insufficiency-A Prospective Study
    Park, Heung-Woo
    Kim, Dong Ki
    Kim, Sae-Hoon
    Kim, Sejoong
    Chae, Dong-Wan
    Yang, Min-Suk
    Oh, Yun Kyu
    Lee, Jung Pyo
    Jung, Jae-Woo
    Shin, Jungho
    Hwang, Jin Ho
    Kang, Min-Gyu
    Kim, Sun Moon
    Kwon, Soon Kil
    Kim, Hye-Young
    Kim, Min-Hye
    Kim, Seung-Jung
    Ryu, Dong-Ryeol
    Cho, Young-Joo
    Jee, Young-Koo
    Kim, So Mi
    Lee, Eun Kyoung
    Kim, Ju-Young
    Cho, Hyun Seop
    Jeong, Yi Yeong
    Kim, Sang-Heon
    Jun, Jae-Bum
    Park, Joon-Sung
    Kim, Gheun-Ho
    Kim, Sujeong
    Jung, Hee-Yeon
    Lee, Jong-Myung
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2019, 7 (04): : 1271 - 1276
  • [30] Cost effectiveness analysis of HLA-B*58:01 genotyping prior to initiation of allopurinol for gout
    Plumpton, Catrin O.
    Alfirevic, Ana
    Pirmohamed, Munir
    Hughes, Dyfrig A.
    RHEUMATOLOGY, 2017, 56 (10) : 1729 - 1739
12345